Basis: Trailing twelve months (TTM). Source: stored company filings and market data; unavailable inputs remain N/A.
The enterprise value (EV) is $17.11M.
ENTERPRISE VALUE (EV)
$17.11M
Immuneering Corporation
Market Cap
$145.75M
Enterprise Value (EV)
$17.11M
| NAME | MARKET CAP | ENTERPRISE VALUE (EV) |
|---|---|---|
| Immuneering Corporation (IMRX) | $145.75M | $17.11M |
| Korsana Biosciences, Inc. (KRSA)vs › | $146.58M | $145.19M |
| NervGen Pharma Corp. Common stock (NGEN)vs › | $147.54M | $86.34M |
| LifeMD, Inc. (LFMDP)vs › | $147.97M | $128.84M |
| Nyxoah S.A. (NYXH)vs › | $143.60M | $130.42M |
| AirSculpt Technologies, Inc. (AIRS)vs › | $141.83M | $193.47M |
| Acumen Pharmaceuticals, Inc. (ABOS)vs › | $150.96M | $123.08M |
| Anavex Life Sciences Corp. (AVXL)vs › | $152.45M | $34.12M |
| Fortress Biotech, Inc. (FBIOP)vs › | $139.73M | $7.94M |
| Alpha Cognition Inc (ACOG)vs › | $139.63M | $98.24M |
Market Cap
$145.75M
Total Debt
$0.00
Cash
$128.65M
Enterprise Value
$17.11M
Why use EV instead of Market Cap?
Enterprise Value represents the total value of a company as if you were to acquire it completely - paying for equity while assuming debt and receiving cash.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
